Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) shares crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.68 and traded as low as $0.51. Arch Therapeutics shares last traded at $0.51, with a volume of 240 shares.
Arch Therapeutics Stock Performance
The business has a fifty day simple moving average of $0.68 and a two-hundred day simple moving average of $1.10.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last announced its quarterly earnings results on Monday, August 19th. The biotechnology company reported ($1.44) EPS for the quarter. The company had revenue of $0.03 million during the quarter.
About Arch Therapeutics
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Further Reading
- Five stocks we like better than Arch Therapeutics
- Canadian Penny Stocks: Can They Make You Rich?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- How Investors Can Find the Best Cheap Dividend Stocks
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- 3 Monster Growth Stocks to Buy Now
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
